Literature DB >> 10053183

Inadequate prescription-drug coverage for Medicare enrollees--a call to action.

S B Soumerai1, D Ross-Degnan.   

Abstract

In summary, most low-income elderly and disabled persons lack coverage for important medications, resulting in avoidable deterioration of health among those with chronic illnesses and use of expensive institutional services. Rapidly escalating drug costs, more restrictive drug-coverage policies, and a dramatic increase in the population of elderly and disabled persons will exacerbate these problems. With the current budget surplus, as well as bipartisan concern about health care needs and public concern about drug costs and coverage, it is time to act responsibly and aggressively. We recommend a national replication of the best features of state pharmacy-assistance programs in a federal-state insurance program for low-income Medicare enrollees, either alone or in combination with expanded Medicare coverage. Such a program will reduce the current inequitable situation in which the most vulnerable patients have the least access to medications, with serious medical and economic consequences.

Entities:  

Mesh:

Year:  1999        PMID: 10053183     DOI: 10.1056/NEJM199903043400909

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  18 in total

1.  Policy statements adopted by the Governing Council of the American Public Health Association, November 15, 2000.

Authors: 
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

2.  Medicare prescription coverage and congressional gridlock.

Authors:  S B Soumerai; A S Adams; D Ross-Degnan
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

Review 3.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

4.  Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.

Authors:  Jeanne M Madden; Amy J Graves; Fang Zhang; Alyce S Adams; Becky A Briesacher; Dennis Ross-Degnan; Jerry H Gurwitz; Marsha Pierre-Jacques; Dana Gelb Safran; Gerald S Adler; Stephen B Soumerai
Journal:  JAMA       Date:  2008-04-23       Impact factor: 56.272

5.  Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.

Authors:  Dana Gelb Safran; Michelle Kitchman Strollo; Stuart Guterman; Angela Li; William H Rogers; Patricia Neuman
Journal:  J Gen Intern Med       Date:  2009-10-31       Impact factor: 5.128

6.  Food insecurity and low self-efficacy are associated with health care access barriers among Puerto-Ricans with type 2 diabetes.

Authors:  Grace Kollannoor-Samuel; Sonia Vega-López; Jyoti Chhabra; Sofia Segura-Pérez; Grace Damio; Rafael Pérez-Escamilla
Journal:  J Immigr Minor Health       Date:  2012-08

7.  The demise of Oregon's Medically Needy program: effects of losing prescription drug coverage.

Authors:  Judy Zerzan; Tina Edlund; Lisa Krois; Jeanene Smith
Journal:  J Gen Intern Med       Date:  2007-03-23       Impact factor: 5.128

8.  Improving physicians' knowledge of the costs of common medications and willingness to consider costs when prescribing.

Authors:  Lisa M Korn; Steven Reichert; Todd Simon; Ethan A Halm
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

9.  The effect of depression and cognitive impairment on enrollment in Medicare Part D.

Authors:  Kara Zivin; Mohammed U Kabeto; Helen C Kales; Kenneth M Langa
Journal:  J Am Geriatr Soc       Date:  2009-06-08       Impact factor: 5.562

10.  Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis.

Authors:  Michele Heisler; Hwajung Choi; Allison B Rosen; Sandeep Vijan; Mohammed Kabeto; Kenneth M Langa; John D Piette
Journal:  Med Care       Date:  2010-02       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.